Spotlights

Home/Spotlights

MassBio’s 2018 Industry Snapshot – Boston/Cambridge Leads the Way

Introduction of press release from MassBio: "August 29 - The Massachusetts Biotechnology Council (MassBio) released its 2018 Industry Snapshot report, which shows that Massachusetts biotechs dominated the IPO market in 2017, accounting for nearly half of all US-based biotech IPOs (48%), up from 30% in 2016. 2018 has already outpaced 2017 in terms of total Massachusetts IPOs [...]

September 3rd, 2018|

Spotlight: First Coast Tech Hubs Gather @ RESI Boston

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series The First Coast Innovator’s Gathering is a new component of the Redefining Early Stage Investments (RESI) Conference Series which was requested by the investors and strategic channel partners who routinely attend RESI. Many of these partners wanted LSN to bring the “earliest stage” [...]

August 23rd, 2018|

Spotlight: BIOWeek:Boston 2018

BIOWeek:Boston 2018 The Complete Guide to the Week of the BIO International Convention June 3-8, 2018 Big3Bio Releases The First Version of BIOWeek:Boston 2018, The Complete Guide to the Week of #BIO2018       SAN FRANCISCO, CA–(May 25, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay [...]

May 27th, 2018|

May Financial Focus: Boston Area a Hot-Bed for Biopharma Startups

By Marie Daghlian VC funding for Boston area biotech companies is on fire and its momentum shows no signs of slowing up. Boston area biotech and health-related companies raised $1.58 billion in 32 deals in the first quarter of 2018. That compares favorably with the $1.59 billion raised in Q4 2017 in 42 deals, and [...]

May 14th, 2018|

Spotlight Q&A with Rob Neville, CEO, Savara Pharmaceuticals

About Savara Pharmaceuticals: Savara Inc. (NASDAQ: SVRA) is an orphan lung disease company. Savara's pipeline comprises a number of late stage therapeutics each targeting difficult to treat lung diseases. Rob Neville CEO, Savara Pharmaceuticals For people not familiar with Savara, can you provide a brief overview and focus? Neville: Savara was founded in [...]

April 2nd, 2018|

Spotlight: Virginia Capezio from TriNet Talks About How Biotech Companies Can Tackle the Tough HR Considerations in 2018

Virginia Capezio is a senior human resources consultant with TriNet, a company that provides full-service HR solutions to small and midsize businesses. Here, Virginia talks about the changing landscape of the biotech workplace, how broader trends may be affecting the environment and the big HR issues biotech companies should be thinking about in the new [...]

January 8th, 2018|

Advancing Drug Development Forum – Making the Impossible Possible

Time: 08:30-19:30 Registration fees: Academic Attendee:  $195, General Attendee:  $395 Register here: Click here to register for this event   Forum description: Register for this ground-breaking inaugural event to explore new solutions, promising technology breakthroughs and how industry can introduce and incorporate improved approaches in drug development. The program, proudly sponsored by Juniper Pharma Services, [...]

November 10th, 2017|

From Candidate Selection to Market: Navigating Challenges in Biotechnology

  Not every drug development program follows a similar path to regulatory approval. Don’t miss out on this Charles River workshop which will bring together industry professionals to provide guidance on key components and considerations for designing and optimizing your drug development program. The workshop will include interactive sessions to discuss how to attract investors, [...]

October 10th, 2017|
X